Front. Bioeng. Biotechnol.Frontiers in Bioengineering and BiotechnologyFront. Bioeng. Biotechnol.2296-4185Frontiers Media S.A.73111910.3389/fbioe.2021.731119Bioengineering and BiotechnologyEditorialEditorial: Advances in the Understanding of Tumor Microenvironment: Molecular and Theranostic ImagingWang et al.Editorial: Tumor Microenvironment ImagingWangShouju1*MaoHui2ChengZhen3TengZhaogang4SunXiaolian5
Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, GA, United States
Molecular Imaging Program at Stanford, Department of Radiology and Bio-X Program, Canary Center at Stanford for Cancer Early Detection, Stanford University, Stanford, CA, United States
Key Laboratory for Organic Electronics and Information Displays, Jiangsu Key Laboratory for Biosensors, Institute of Advanced Materials, Jiangsu National Synergetic Innovation Centre for Advanced Materials, Nanjing University of Posts and Telecommunications, Nanjing, China
State Key Laboratory of Natural Medicines, Key Laboratory of Drug Quality Control and Pharmacovigilance, Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing, China
Edited and Reviewed by:Hasan Uludag, University of Alberta, Canada
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Editorial on the Research TopicAdvances in the Understanding of Tumor Microenvironment: Molecular and Theranostic Imagingtumour microenvironmentmolecular imagingtheranosticsimmune microenvironmentnanoprobes
Tumor microenvironment (TME) plays key roles in cancer development, prognosis and responses to treatments. However, given its heterogeneity and complex interactions/interplays with other malignant processes, investigating TME requires systematical and preferably non-disruptive approaches. Molecular imaging enables visualizing, characterizing, and even quantitatively measuring specific biological and molecular processes in vivo to monitor the heterogeneity and evolution of TME. Theranostic imaging, as a rapidly expanding facet of molecular imaging, also creates new possibilities to deploy treatment options targeting TME by delivering therapeutic agents or disruptive photothermal and photodynamic energy. The advanced molecular and theranostic imaging tools and approaches presented in this special issue, including one review article, one mini review article, and two original research articles, offer an overview and a few examples of such applications.
Focusing on immune therapy that aims to reverse the immune-suppressive TME, Li et al. provided a latest overview of the recent progress of breast cancer treatments, including the predictive biomarkers, immune checkpoint blockades, cancer vaccines, and adoptive cell therapy, which directly or indirectly changed TME to exert the efficacy. In this mini review article, the authors highlighted the potential of nanotechnology to monitor and control the tumor immune microenvironment. Gao et al. introduced the therapeutic applications of gold nanoparticles in cancer treatment and discussed the potential of using stimuli-responsive strategies to respond to TME and to increase the transport efficacy. Serval unique properties, such as localized surface plasma resonance and stimuli-responsive properties to hypoxia and acidic pH, making gold nanoparticles promising for transport therapeutic drugs to TME. In a research report, Heaster et al. demonstrated intravital metabolic autofluorescence imaging can be used to resolve the dynamic macrophage function and reveal the heterogeneity of macrophage between normal and cancerous microenvironments in vivo. This method enabled autofluorescence imaging to monitor macrophage behavior in response to treatment, which would be helpful to identify new targets for drug development. Finally, Wang et al. present a rationally designed sandwich nanostructure of gold-graphene hybrid material that can be used for photoacoustic image-guided photothermal therapy. The imaging-guided photothermal therapy could precisely control the temperature of the tumor and potentially alter the TME through the disruption of its specific components.
As this Research Topic on this issue covers the recent advances in molecular and theranostic imaging of TME, it should be noted that the potential of nanotechnology and molecular imaging applications in imaging and modulation of TME has yet to be fully explored. The editors hope that the selected articles on this Research Topic will inspire future work to further advance and expand molecular and theranostic imaging in studying TME and beyond.
Author Contributions
All authors listed have made a substantial, direct and intellectual contribution to the work, and approved it for publication.
Funding
This work received funding from the National Natural Science Foundation of China (Nos 82022034 and 81871420) and Jiangsu Province Natural Science Foundation of China (No. BK20200032).
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.